Polymer Laboratories Inc - - BioPharm International

ADVERTISEMENT

Polymer Laboratories Inc

BioPharm International
Volume 18, Issue 12

Company Description



Polymer Laboratories (PL) specializes in developing and manufacturing high-grade polymeric particles for HPLC columns (nano through process-scale), solid- and solution-phase synthesis supports for high throughput organic synthesis and peptide synthesis; and polymers for clinical diagnostics, including paramagnetic particles for bioseparations.

PL's media and resins are manufactured under the ISO 9001:2000 Quality Management System.The company has 29 years' experience in polymers and polymer particles for high-technology applications.



PL is an international company with offices and laboratories in the US and Europe which, together with an established global distributor network, offer worldwide sales, technical support, and service.

Chief Biopharmaceutical Techniques Supported

  • Synthesis
  • Analysis
  • Purification

Facilities



State-of-the-art manufacturing facilities opened in 2001, with a capacity greater than 4 M tons of high- performance particles, establishing PL as one of the world's largest chromatographic and solid phase synthesis particle manufacturers. The company's facilities are ISO 9001:2000 accredited.

PL also provides stringently controlled specialized production of particles for biological applications.

Major Products

  • HPLC columns and media
  • Synthesis supports
  • Paramagnetic particles

Markets Served

  • Biotherapeutic synthesis and purification
  • Biomolecule synthesis and purification
  • Diagnostics

POLYMER LABORATORIES INC
Amherst Fields Research Park 160 Old Farm Road, Amherst, MA 01002

TELEPHONE
413.253.9554

FAX
413.253.2476

E-MAIL

WEB ADDRESS
http://www.polymerlabs.com/

EMPLOYEES
175 worldwide

FOUNDED
1976

blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here